Utama › Hemofilia › Pennsylvania
Kajian klinikal Hemofilia di Pennsylvania
6 kajian untuk Hemofilia sedang mencari peserta di lokasi di Pennsylvania.
Bandar di Pennsylvania
Teks kajian rasmi (Bahasa Inggeris)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- The Childrens Hospital of Philadelphia Division of Hematology, Philadelphia
- The Childrens Hospital of Philadelphia Division of Hematology, Philadelphia
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 2 Okt 2026 · NCT05568719A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
- Penn State MS Hershey Med Ctr, Hershey
- St Christopher Hosp for Child, Philadelphia
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 64 · Lelaki · Dikemas kini 18 Sep 2026 · NCT07220564ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Children's Hospital of Philadelphia, Philadelphia
- Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania, Philadelphia
- St. Christopher's Hospital for Children, Philadelphia
- dan 1 lagi
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT04398628A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
- Penn State Milton S Hershey Medical Center Pediatrics, Hershey
- Perelman Center for Advanced Medicine (PCAM)- Penn Blood Disorders Program, Philadelphia
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 60 · Semua jantina · Dikemas kini 2 Jul 2026 · NCT06349473Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- The Feinstein Institutes for Medical Research, Philadelphia
Mengambil pesertaFasa 3
Umur 1 hingga 74 · Lelaki · Dikemas kini 1 Jul 2026 · NCT05145127Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- Penn State College of Medicine, Hershey
Mengambil pesertaFasa 1
Umur 0 hingga 90 · Semua jantina · Dikemas kini 3 Apr 2026 · NCT05500807Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.